PsychoGenics Appoints David A. Lowe, as Chief Scientific Officer and Executive Vice President of Research and Development

TARRYTOWN, N.Y., August 10, 2009 – PsychoGenics Inc., announced the appointment of David A. Lowe, Ph.D., as Chief Scientific Officer (CSO) and Executive Vice President of Research and Development (EVP, R&D).